Monitor the upcoming conference call for commentary on margins and SG&A trends. The EPS miss could weigh on the stock, but strong revenue growth and raised guidance may provide support. Look for sequential revenue acceleration and free cash flow trajectory as key catalysts.
Price Chart
Executive Summary
Viemed reported Q1 2026 revenue of $75.4M (+28% YoY), beating internal trends, but GAAP diluted EPS of $0.06 missed the $0.09 consensus by 33%. Adjusted EBITDA grew 12% to $14.3M. The company narrowed and raised full-year revenue guidance to $312-320M and lowered capex outlook, while reaffirming EBITDA guidance. The mixed result of strong top-line growth and improved guidance offset by a meaningful EPS miss pressures the stock near term.
Key Financial Metrics
Key Facts
- Revenue $75.4M in Q1 2026, +28% YoY from $59.1M
- GAAP diluted EPS $0.06, flat YoY but missed consensus of $0.09
- Adjusted EBITDA $14.3M, +12% YoY (prior year benefited from $2.7M non-recurring gain)
- Full-year 2026 revenue guidance narrowed and raised to $312M-$320M from $310M-$320M
- Adjusted EBITDA guidance reaffirmed at $65M-$69M
- Net capex guidance lowered to 9%-10.5% of revenue from 10%-11.5%
- Operating cash flow $8.1M, free cash flow $2.6M in Q1
- Sleep PAP therapy patients up 57% YoY; ventilator patients up 2%
Financial Impact
EPS miss of $0.03 vs consensus ($0.06 vs $0.09) represents a 33% shortfall; revenue beat not quantified due to absence of consensus
Risk Factors
- GAAP EPS miss of 33% vs consensus may lead to short-term selling pressure
- SG&A grew 22% YoY, outpacing revenue growth and compressing margins
- Flat net income despite 28% revenue growth raises questions about operating leverage
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001729149-26-000028 |
| Document: vmd-20260505.htm | 0001729149-26-000028 |
| Document: viemed_q12026supplementa.htm | 0001729149-26-000028 |
| Document: 0001729149-26-000028-index-headers.html | 0001729149-26-000028 |
| Document: 0001729149-26-000028-index.html | 0001729149-26-000028 |
| Document: 0001729149-26-000028.txt | 0001729149-26-000028 |
| 8-K Data (Synthetic) | 0001729149-26-000028 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 24, 2026 4w ago | SC 13D/A | $8.91 $9.11 | ▼ −2.24% | ▼ −2.99% | $9.73 (−9.20%) |
Aug 20, 2026 9w ago | 8-K | $8.85 $9.09 | ▲ +2.71% | ▲ +3.01% | $9.73 (+9.94%) |
Aug 3, 2026 12w ago | 8-K | $9.84 $9.82 | ▼ −0.15% | ▲ +0.05% | $9.73 (−1.07%) |
Jun 4, 2026 20w ago | 8-K | $9.97 $9.92 | ▼ −0.50% | ▼ −0.73% | $9.73 (−2.41%) |
Jun 2, 2026 20w ago | 8-K | $9.56 $9.84 | ▲ +2.93% | ▲ +2.53% | $9.73 (+1.78%) |
May 5, 2026 24w ago | 8-K | $8.52 $8.52 | · 0.00% | ▲ +0.33% | $9.73 (+14.27%) |
Mar 4, 2026 33w ago | 8-K | $8.40 $8.78 | ▲ +4.52% | ▲ +5.84% | $9.73 (+15.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers